HINGHAM, Mass., Sept. 02, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (MBOT) announced, as part of the preparation for its anticipated U.S. Food and Drug Administration (FDA) and CE Mark ...
VANCOUVER, Washington, Feb. 01, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for ...
Channel Therapeutics announced successful pre-clinical results for its non-opioid pain treatment formulations, outperforming bupivacaine in efficacy and duration. Channel Therapeutics Corporation has ...
In a preclinical study, rodents treated with uric acid showed improved long-term outcomes after acute ischemic stroke. The findings suggest that the treatment may work as an add-on therapy to standard ...
A research team from Virginia Commonwealth University has found that a drug currently in clinical trials for brain disorders such as Alzheimer's disease might also have potential for treating alcohol ...
NIR-II imaging has many advantages for preclinincal research as it supports deeper visualization with lower scattering and autofluorescence.
A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials. A new vaccine that boosts immunity against tuberculosis (TB) has been ...
Immuron Limited Reports Strong Sales Projections and Updates on Clinical Trials and Product Launches
Immuron Limited has announced strong progress in several key projects, including expected sales exceeding A$7 million this financial year, a significant increase from last year’s A$4.9 million. The ...
Division of Surgery and Interventional Science, University College London, London, United Kingdom; Basic and Translational Cancer Research Group, College of Medicine, University of Nigeria, Enugu, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results